COMMUNIQUÉS West-GlobeNewswire

-
OrganOx metra® Receives FDA Approval for Operation During Air Transport, Expanding Access to Life-Saving Liver Perfusion Technology
18/09/2025 -
Dark Horse Consulting Group Acquires Converge Consulting
18/09/2025 -
After Transforming Neuro Care, Sevaro Secures $39M to Expand AI-Powered Specialty Care Platform
18/09/2025 -
Senti Bio to Present at the MedInvest Biotech & Pharma Conference
18/09/2025 -
HCW Biologics, a Shareholder of Wugen, Congratulates Wugen on Its Recent Successful Equity Financing
18/09/2025 -
BioCardia Announces Pricing of Up To $12 Million Public Offering
18/09/2025 -
Replimune Provides Update Following Type A Meeting with FDA
18/09/2025 -
First Insight Launches MaximEyes AI, Powered by EVAA
18/09/2025 -
Safety Shot Provides Further Details on Strategic Board Refresh and Corporate Vision
18/09/2025 -
Scientific Industries to Participate in the Lytham Partners Fall 2025 Investor Conference on September 30, 2025
18/09/2025 -
TOMI Environmental Solutions, Inc. Announces FDA Broadens Permitted Use of Hydrogen Peroxide; Ruling Significantly Expands Potential Application of SteraMist iHP in Food Industry
18/09/2025 -
Confluent Health Strengthens Leadership to Advance Innovation and Culture in MSK Care
18/09/2025 -
SeoProfy Introduces AI SEO Audit to Track LLM Visibility
18/09/2025 -
Commure Awarded as a TIME World’s Top HealthTech Company in 2025
18/09/2025 -
Noom Welcomes Rebel Wilson as Chief Wellness Ambassador to Champion Microhabits and Microdose GLP-1s
18/09/2025 -
PDS Biotech Sets Significant Benchmark in Head and Neck Cancer by Achieving Extended Survival in Low PD-L1 Expression (CPS 1–19) Cohort in VERSATILE-002 Trial, Potentially Eliminating Need for Chemotherapy in the Population
18/09/2025 -
Jyong Biotech Chairwoman and CEO Set to Attend as Speaker at 2025 Global Business Forum in Taipei
18/09/2025 -
Oncotelic Therapeutics Inc. (OTCQB: OTLC) Creating Pioneering Pipeline Designed to Transform Cancer, Rare Diseases Treatments
18/09/2025 -
Clover Health Celebrates the Election of Dr. Ian Duncan, Clover MA Board Member, as the 2025-2026 President-Elect and Vice-Chair of the Society of Actuaries
18/09/2025
Pages